ADDITIONAL READING

  1. American Association of Clinical Endocrinologists: Comprehensive Type 2 Diabetes Management Algorithm (2020) — Executive Summary. https://www.aace.com/disease-state-resources/diabetes/clinical-practice-guidelines-treatment-algorithms/comprehensive.
  2. Solomon, SD, Chew E, Duh EJ, et al. Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40:412–418. http://care.diabetesjournals.org/content/40/3/412.
  3. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of dyslipidemia and prevention of cardiovascular disease. https://www.aace.com/disease-state-resources/lipids-and-cv-health/clinical-practice-guidelines/aaceace-guidelines.
  4. American Diabetes Association. Standards of Medical Care in Diabetes 2020. Diabetes Care. 2020; 43 (Supplement 1). https://care.diabetesjournals.org/content/43/Supplement_1.
  5. Center for Disease Control and Prevention. Chronic disease prevention and health promotion. https://www.cdc.gov/chronicdisease/resources/publications/aag/diabetes.htm.
  6. Segal AR, et al. Insulin: making sense of current options. Endocrinol Metab Clin North Am. 2016;45(4):845–874.
  7. Roth EG, et al. Diabetes and the motivated patient: understanding perlocutionary effect in health communication. Health Commun. 2017;32(4):502-508.
  8. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62-S69.
  9. Baptista DR, et al. The chronic care model for type 2 diabetes: a systematic review. Diabetol Metab Syndr. 2016;8:7.
  10. Hewston P, Deshpande N. The short version of the activities-specific balance confidence scale for older adults with diabetes-convergent, discriminant and concurrent validity: a pilot study. Can J Diabetes. 2017;41(3):266-272.
  11. American Diabetes Association. Strategies for improving care. Diabetes Care. 2016;39(Supplement 1): S6-S12.
  12. American Association of Clinical Endocrinologists. Diabetes Resource Center. https://www.aace.com/disease-state-resources/diabetes.
  13. Micha R, Peñalvo JL, Cudhea F, et al. Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States. JAMA. 2017;317(9):912-924.
  14. Otto MC, Afshin A, Micha R, et al; Global Burden of Diseases, Injuries, and Risk Factors Metabolic Risk Factors of Chronic Diseases Expert Group; Nutrition and Chronic Diseases Expert Group (NutriCoDE). The impact of dietary and metabolic risk factors on cardiovascular diseases and type 2 diabetes mortality in Brazil. PLoS One. 2016;11(3):e0151503.
  15. Yang CJ, Hsu HY, Lu CH, et al. Do we underestimate influences of diabetic mononeuropathy or polyneuropathy on hand functional performance and life quality? J Diabetes Investig. 2018;9(1):179-185.
  16. Stino AM, Smith AG. Peripheral neuropathy in prediabetes and the metabolic syndrome. J Diabetes Investig. 2017;8(5):646-655.
  17. Strain WD, Agarwal AS, Paldánius PM. Individualizing treatment targets for elderly patients with type 2 diabetes: factors influencing clinical decision making in the 24-week, randomized INTERVAL study. Aging (Albany NY). 2017;9(3):769-777.
  18. Brahimaj A, Ligthart S, Ghanbari M, et al. Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study. Eur J Epidemiol. 2017;32(3):217-226.
  19. Hutchison AT, Wittert GA, Heilbronn LK. Matching meals to body clocks-impact on weight and glucose metabolism. Nutrients. 2017;9(3). pii: E222.
  20. Wise J. Complications are more common in young people with type 2 diabetes than type 1. BMJ. 2017 Mar 1;356:j1082.
  21. Kuhn A, Park J, Ghazi A, Aroda VR. Intensifying treatment beyond monotherapy in type 2 diabetes mellitus: where do newer therapies fit? CurrCardiol Rep. 2017;19(3):25.
Font Size